Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
04/13/2000 | WO2000020573A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
04/13/2000 | WO2000020560A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
04/13/2000 | WO2000020555A2 Transformation system in the field of filamentous fungal hosts: in chrysosporium |
04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
04/13/2000 | WO2000020456A1 Novel g protein-coupled receptor protein and dna thereof |
04/13/2000 | WO2000020452A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
04/13/2000 | WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor |
04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
04/13/2000 | WO2000020040A1 Controlling gene expression in living cells |
04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
04/13/2000 | WO2000011214B1 Molecular differences between species of the m. tuberculosis complex |
04/13/2000 | WO2000003015A3 Human transport protein homologs |
04/13/2000 | WO2000003010A3 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
04/13/2000 | WO2000000620A3 Dna encoding methymycin and pikromycin |
04/13/2000 | WO2000000608A3 Immune system molecules |
04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
04/13/2000 | WO1999063094A3 Nucleotide and protein sequences of gpr1 and methods based thereon |
04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
04/13/2000 | WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use |
04/13/2000 | DE19846838A1 Recombinant Drosophila deoxynucleotide kinase useful for preparing nucleoside monophosphates by phosphorylating nucleosides |
04/13/2000 | DE19846493A1 DNA sequence coding for products involved in the biosynthesis of polyketide or heteropolyketide compounds, especially epothilone |
04/13/2000 | CA2653985A1 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
04/13/2000 | CA2346134A1 G protein-coupled receptor resembling the thrombin receptor |
04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
04/13/2000 | CA2345203A1 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
04/13/2000 | CA2344973A1 Oxidoreductase molecules |
04/13/2000 | CA2344593A1 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
04/13/2000 | CA2344459A1 Novel g protein-coupled receptor protein and dna thereof |
04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
04/13/2000 | CA2341351A1 Alpha-2/delta gene |
04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
04/13/2000 | CA2284850A1 Dna coding for protein which confers on bacterium escherichia coli resistance to l-homoserine, and method for producing l-amino acids |
04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
04/12/2000 | EP0992586A2 Extracellular matrix proteins with modified amino acid |
04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
04/12/2000 | EP0992579A1 Stem cell factor |
04/12/2000 | EP0991778A1 Biosensor materials and methods |
04/12/2000 | EP0991775A1 Method to identify pesticidal microbes |
04/12/2000 | EP0991774A1 Method for increasing secretion of proteins in eukaryotic host cells |
04/12/2000 | EP0991770A2 Prostate cancer gene |
04/12/2000 | EP0991768A1 Sucrose-binding proteins |
04/12/2000 | EP0991767A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
04/12/2000 | EP0991758A1 Smad6 and uses thereof |
04/12/2000 | EP0991754A2 Proteases from gram-positive organisms |
04/12/2000 | EP0991663A1 $i(MYCOBACTERIUM) STRAIN WITH MODIFIED $i(ERP) GENE AND VACCINE COMPOSITION CONTAINING SAME |
04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
04/12/2000 | CN2373453Y Compound field three-D cell culturing device |
04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
04/12/2000 | CN1250102A Process for preparing fermented product and stress resistance microbe |
04/12/2000 | CN1250056A Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
04/12/2000 | CN1250055A Production of recombination human lactoferritin |
04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
04/11/2000 | US6048839 Materials and methods for controlling insect pests with pesticidal proteins obtainable from Bacillus thuringiensis isolates PS158C2 and HD511 |
04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
04/11/2000 | US6048713 Pseudomonas fluorescens |
04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
04/11/2000 | US6048694 Screening for gram positive bacterial transformed with heterologus nucleic acids; constructing vector and inserting nucleic acids, destroying enzyme activity, transforming cell defective in sucrose metabolism, isolating transformant |
04/09/2000 | CA2639757A1 Amino acid modified polypeptides |
04/09/2000 | CA2639637A1 Amino acid modified polypeptides |
04/09/2000 | CA2639620A1 Amino acid modified polypeptides |
04/09/2000 | CA2284117A1 Process for the preparation of pantothenic acid by amplification of nucleotide sequences which code for ketopantoate reductase |
04/06/2000 | WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
04/06/2000 | WO2000018947A1 Fermentation of clavulanic acid at a controlled level of ammonia |
04/06/2000 | WO2000018937A1 Maize glutathione-s-transferase enzymes |
04/06/2000 | WO2000018936A1 Soybean glutathione-s-transferase enzymes |
04/06/2000 | WO2000018935A1 Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium |
04/06/2000 | WO2000018934A1 Peptidyl prolyl cis-trans isomerases |
04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
04/06/2000 | WO2000018924A1 Human small proline-rich molecule |
04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
04/06/2000 | WO2000018916A2 Human genes and gene expression products |
04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
04/06/2000 | WO2000018914A2 Novel dkr polypeptides |
04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |
04/06/2000 | WO2000018906A2 Shuffling of codon altered genes |